Loading company…
Novotech is a Sydney clinical development services provider for biotechnology companies, founded in 1997.
Founded in 1997 as the Asia Pacific CRO, Novotech (Australia) Pty Limited is based in Sydney, Australia, and provides clinical development services such as audits, clinical trials, biostatistics, data processing, medical writing and regulatory affairs. It has supported over a thousand Phase I-IV clinical trials. In 2020, Novotech and PPC, both majority-owned by TPG Capital Asia, merged to form Novotech Health Holdings, which is preparing an initial public offering in Hong Kong.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in